- Research article
- Open Access
Characterization of the interaction between Actinin-Associated LIM Protein (ALP) and the rod domain of α-actinin
© Klaavuniemi et al; licensee BioMed Central Ltd. 2009
- Received: 23 December 2008
- Accepted: 27 March 2009
- Published: 27 March 2009
The PDZ-LIM proteins are a family of signalling adaptors that interact with the actin cross-linking protein, α-actinin, via their PDZ domains or via internal regions between the PDZ and LIM domains. Three of the PDZ-LIM proteins have a conserved 26-residue ZM motif in the internal region, but the structure of the internal region is unknown.
In this study, using circular dichroism and nuclear magnetic resonance (NMR), we showed that the ALP internal region (residues 107–273) was largely unfolded in solution, but was able to interact with the α-actinin rod domain in vitro, and to co-localize with α-actinin on stress fibres in vivo. NMR analysis revealed that the titration of ALP with the α-actinin rod domain induces stabilization of ALP. A synthetic peptide (residues 175–196) that contained the N-terminal half of the ZM motif was found to interact directly with the α-actinin rod domain in surface plasmon resonance (SPR) measurements. Short deletions at or before the ZM motif abrogated the localization of ALP to actin stress fibres.
The internal region of ALP appeared to be largely unstructured but functional. The ZM motif defined part of the interaction surface between ALP and the α-actinin rod domain.
- Surface Plasmon Resonance
- Stress Fibre
- Yellow Fluorescent Protein
- Nuclear Magnetic Resonance Analysis
- Tobacco Etch Virus Protease
The muscle Z disc connects actin filaments from adjacent sarcomeres and is essential for force transmission and muscle integrity (for a recent review, see ). The main actin cross-linking protein in the Z disc is α-actinin, an antiparallel dimer. Each of the α-actinin monomers is composed of an N-terminal actin binding domain, a central rod region containing four spectrin repeats, and two pairs of EF-hands at the C-terminus (for review [2, 3]).
The PDZ domains of many, if not all, of these proteins interact with the C-terminal peptide of α-actinin [6, 23, 25–27]. In addition, ALP, ZASP/Cypher and CLP36 interact with the α-actinin rod domain [27–29] via sequences located between the PDZ and LIM domains, mapping close to a conserved 26 amino acid motif, the ZM motif, found in these three proteins [27, 29]. Point mutations at or close to the ZM motif of ZASP/Cypher are found in cardiomyopathy patients [30, 31], but we have been unable to detect a direct effect of these mutations on interaction with α-actinin .
The ZM motif is located in a sequence stretch of 200 or more residues between the PDZ and LIM domains of the ALP, ZASP/Cypher and CLP36, designated here as the internal region. Apart from the ZM motif and the recently found ALP-like motif , sequence diversity in the internal region is high, and in all family members there are areas 30–100 amino acid in length that are predicted to be unfolded by the program FoldIndex . In this study, the aim was to structurally characterize the internal region of ALP and to further narrow its interaction site with the α-actinin rod region. The ALP internal region was found to be essentially a random coil in solution and interaction with the α-actinin rod could increase its stabilization. Furthermore, we found that a synthetic peptide covering part of the ZM motif interacted directly with the α-actinin rod.
Expression and purification of ALP internal region fragments
Functional tests of ALP107-273
Taken together, the SRP interaction measurements and live cell experiments using YFP fusion protein indicated that ALP107-273 interaction with α-actinin was similar to the full length ALP .
Structural characterization of ALP107-273
The interaction with the α-actinin rod region could have induced some structural changes in ALP107-273. Assessing this by titration was complicated because the complex between ALP107-273 and the large α-actinin rod dimer of 114 kDa was undetectable by NMR. To be able to measure the spectrum of an unbound ALP107-273 that is in dynamic equilibrium between α-actinin bound and unbound states, we used a rather low concentration of ALP107-273 and observed increasing levels of ALP107-273 15N-HSQC peaks upon addition of α-actinin (Fig 5C). Most of the peaks (110, or 75%) could be correlated with those assigned in the presence of 40 mM Aspartic acid. Only a minor fraction of the peaks were induced by ALP dilution alone (Fig 5D). The NMR titration studies suggested that structure of ALP107-273 was partially stabilized by the interaction with the α-actinin rod region.
Mapping of the interaction site with synthetic peptides and deletions
α-Actinin interacting PDZ-LIM proteins are important for sarcomeric integrity as well as being involved in hypertrophic stretch activated signalling pathways in the muscle Z disc (for reviews, see [40–43] via their interactions with protein kinase C isoforms and calsarcins [9, 22, 23, 30, 31, 44, 45]. Although the PDZ and LIM domains are well-known protein folds, the functional and structural properties of the internal regions in this family of proteins are still poorly characterized.
In previous studies, we showed that ALP, CLP36 and ZASP/Cypher, which all have a ZM motif in the internal region, interacted with the α-actinin rod and that the ZM motif (ALP residues 184–209) might be important for this interaction [27, 29]. In the current paper, we have been able to map the interaction site in more detail. We showed that a synthetic peptide spanning ALP residues 175–196 was able to interact directly with the α-actinin rod. Two other peptides spanning parts of the ZM motif did not interact and neither did two peptides before the ZM motif. On the other hand, several deletion mutants before or at the ZM motif abrogated the localization of YFP-ALP fragments to α-actinin containing structures. Notably, a deletion after the ZM motif had no effect. A mutation at the conserved Tyr-Ser sequence in the ZM motif (residues 197–198) also abrogated localization of ALP in cells. Further studies are required to test whether this effect is dependent on phosphorylation, and whether phosphorylation could explain the lack of ALP in focal adhesions where α-actinin is located.
Thus, our peptide binding studies and deletion mutations suggest that the ZM motif is directly involved in the interaction with the α-actinin rod. However, these results do not rule out the involvement of other areas of the ALP internal region in the interaction. On the contrary, the involvement of other areas was suggested by the finding that while peptide 3 interacted strongly with the α-actinin rod fragment composed of four spectrin repeats (R1-R4), it did not interact with the two central spectrin repeats (R2-R3) of α-actinin. The ALP107-273 fragment, on the other hand, interacted with both R1-R4 and R2-R3 fragments. These data are compatible with a hypothesis that the ALP internal region may have an extended interaction surface on α-actinin and that the interaction surface may cover a large area of the α-actinin rod domain.
Structural analysis showed that the ALP internal region is largely unstructured and that interaction with α-actinin partially stabilizes its conformation, but does not induce any detectable secondary structure elements. We showed previously that two ALP molecules can interact with the dimeric α-actinin rod domain . Combining this information with our current structural and hydrodynamic analyses suggests that the ALP internal region is an elongated, flexible monomer in solution, although we cannot exclude the formation of dimer. Notably, despite a lack of ordered structure, this fragment is rather stable and it can be expressed, purified and concentrated to a high degree. Based on sequence analysis by programs such as FoldIndex  or DisEMBL , the ALP internal region cannot be classified as being intrinsically unfolded (Fig 2). Analysis of the corresponding regions of other PDZ-LIM family members with the same programs yielded quite similar results (data not shown).
Our current data are compatible with the hypothesis that the ALP internal region exists in an open, flexible conformation and forms a long interaction surface with the α-actinin rod region. We have also shown that sequences both before and at the conserved ZM motif are required for interaction with α-actinin and that a short peptide from this area can interact directly.
Internal fragments of human ALP (AF039018) and chicken ALP (AJ249218) were cloned into a modified pET24d vector (Novagen, Merck Biosciences, Schwalbach, Germany) as described earlier  using BsmBI (NcoI)- NotI cloning sites. Rod fragments containing spectrin repeats 1–4 (residues 274–746) or repeats 2 and 3 (residues 371–637) of human α-actinin 2 have been described previously [46, 47]. A YFP-fusion of ALP107-273 was generated in a pEYFP-C1 vector (Clontech, BD Biosciences) at an EcoRI-BamHI restriction site. The deletion constructs of pEYFP-ALP107-273 were generated by PCR. The α-Actinin-CFP construct is described elsewhere . All constructs were verified by DNA sequencing.
Protein expression and purification
ALP internal fragments and an α-actinin rod containing the spectrin repeats 1–4 (R1-R4) and a fragment containing spectrin repeats 2 and 3 (R2-R3) were expressed at +37°C for 3–4 h in Escherichia coli BL21(DE3) strain as previously described . Briefly, proteins were purified using nickel nitrilotriacetic acid-agarose (Qiagen) as a first step. The His-tag was removed by tobacco etch virus protease (Invitrogen). For further purification, size exclusion chromatography (Superdex 75 16/60 and 26/60 columns, Amersham Biosciences) for ALP, and ion exchange (ProteinPakQ 8HR columns, Waters) for α-actinin fragments were used. The molecular weight standards for the gel filtration were obtained from Bio-Rad Laboratories. For NMR analysis, 15N-labelled ALP107-273 and 15N13C-labelled ALP107-273 were produced in general M9-media with supplements . Expression was induced with 1 mM isopropyl-1-thio-β-D-galactopyranoside (IPTG) at +37°C for 8 hrs in E. coli BL21(DE3) strain. Low molecular weight markers used in SDS-polyacrylamide electrophoresis were obtained from Amersham Biosciences. Five ALP peptides were purchased from EZBiolab Inc. (Westfield, IN, USA).
A JASCO J-715 spectrometer (JASCO Corporation, Hachioji City, Tokyo, Japan) was used for circular dichroism measurements. Purified ALP proteins at a concentration of approximately 30 mg/ml were diluted to 0.15 mg/ml with 20 mM Tris, pH 8 buffer. The far-UV spectrum (195–250 nm) was measured at 20°C and the background effect of buffer was subtracted. The instrument settings were as follows: response 1 sec, scan speed 50 nm/min, cell length 0.1 mm, number of scans 16.
Localization studies of ALP mutants
The pEYFP ALP107-273 and mutants were transfected into CHO cells as described previously . Following 24 hrs transfection, the cells were seeded for 4 hrs on coverslips coated with 10 μg/ml human plasma fibronectin (Sigma) and fixed with 4% paraformaldehyde in 140 mM NaCl, 10 mM Na-Phosphate pH 7.4. The coverslips were coded and the number of cells with YFP localization at stress fibres was counted by two observers who were blinded to the identity of the samples. At least 100 cells were scored from each coverslip, four coverslips were used per transfection, and the experiment was repeated at least three times.
Live cell microscopy
Human osteosarcoma (U2OS) cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (Hyclone), 2 mM L-glutamine, penicillin and streptomycin (Sigma-Aldrich). Transfected cells were re-plated on fibronectin (10 μg/ml) coated glass bottom dishes (MatTek). General growth medium was used as imaging medium. The time lapse images were acquired with an IX-71 inverted microscope (Olympus) equipped with a Polychrome IV monochromator (TILL Photonics) with the appropriate filters, an Andor iXon (Andor) camera, a heated sample environment (+37°C) and CO2-control. A PLAPON 60xO TIRFM 60x/1,45 (oil) objective (Olympus) was used. Software for image acquisition was TILL Vision version 4 (TILL Photonics).
Nuclear magnetic resonance
After defrosting 100 μl of the purified 15N labelled ALP (1.6 mM) in buffer solution (20 mM TRIS, 150 mM NaCl, 1 mM EDTA and 1 mM DTT, pH 8), a NMR sample of pure ALP was prepared by adding 10% D2O to the defrosted ALP and transferring the sample to a susceptibility matched Shigemi tube (Shigemi Inc., tube matched to water with 8 mm bottom). Initially, a 15N-HSQC spectrum of ALP107-273 was acquired as a reference spectrum. The titration series was initiated by preparing a sample containing 45 nmol ALP, 15 nmol rod domain of α-actinin (R1-R4, 277 μM and 236 μM in 20 mM TRIS and 50 mM NaCl, pH 8), 15 μl buffer solution of R1-R4 and 10% D2O to a susceptibility matched Shigemi tube. A 15N-HSQC spectrum was measured and the titration was continued in a stepwise manner by adding 15 nmol of R1-R4 to the sample and acquiring a new 15N-HSQC spectrum at each titration point, until the ratio of 3:8 (ALP:R1-R4) was reached. As a control, titration of ALP was performed with R1-R4 buffer (20 mM TRIS and 50 mM NaCl, pH 8). In order to enable direct comparison of the 15N HSQC spectra at each data point, identical experimental and processing parameters were employed. Measurements were performed with a Bruker Avance DRX 500 MHz spectrometer (Bruker BioSciences, Billerica, Massachusetts, USA) and a 5 mm triple resonance inverse probehead at room temperature. Measurement of 15N/13C enriched ALP was performed with a Varian Unity INOVA 800 MHz spectrometer (Varian, Palo Alto, California).
Surface plasmon resonance
A Biacore 3000 system (Biacore, Uppsala, Sweden) was used for surface plasmon resonance (SPR) analysis. Ligand immobilization was performed via amine coupling to gold sensor chips (CM5). The running buffer was 20 mM Tris, pH 7.4, 150 mM NaCl, 0.005% surfactant P20 (BR-1000-54, Biacore AB, Uppsala, Sweden).
We thank Minna Leuanniemi for expert purification of α-actinin fragments and Päivi Pirilä for valuable advice in CD spectroscopy. This work was funded by the Academy of Finland research grants 51863, 207021, 105211, and 122170 and by the Finnish Heart Research Foundation.
- Frank D, Kuhn C, Katus HA, Frey N: The sarcomeric Z-disc: a nodal point in signalling and disease. J Mol Med. 2006, 84 (6): 446-468. 10.1007/s00109-005-0033-1.View ArticlePubMedGoogle Scholar
- Blanchard A, Ohanian V, Critchley D: The structure and function of alpha-actinin. J Muscle Res Cell Motil. 1989, 10 (4): 280-289. 10.1007/BF01758424.View ArticlePubMedGoogle Scholar
- Broderick MJ, Winder SJ: Towards a complete atomic structure of spectrin family proteins. J Struct Biol. 2002, 137 (1–2): 184-193. 10.1006/jsbi.2002.4465.View ArticlePubMedGoogle Scholar
- McKeown CR, Han HF, Beckerle MC: Molecular characterization of the Caenorhabditis elegans ALP/Enigma gene alp-1. Dev Dyn. 2006, 235 (2): 530-538. 10.1002/dvdy.20633.PubMed CentralView ArticlePubMedGoogle Scholar
- Xia H, Winokur ST, Kuo WL, Altherr MR, Bredt DS: Actinin-associated LIM protein: identification of a domain interaction between PDZ and spectrin-like repeat motifs. J Cell Biol. 1997, 139 (2): 507-515. 10.1083/jcb.139.2.507.PubMed CentralView ArticlePubMedGoogle Scholar
- Faulkner G, Pallavicini A, Formentin E, Comelli A, Ievolella C, Trevisan S, Bortoletto G, Scannapieco P, Salamon M, Mouly V: ZASP: a new Z-band alternatively spliced PDZ-motif protein. J Cell Biol. 1999, 146 (2): 465-475. 10.1083/jcb.146.2.465.PubMed CentralView ArticlePubMedGoogle Scholar
- Guy PM, Kenny DA, Gill GN: The PDZ domain of the LIM protein enigma binds to beta-tropomyosin. Mol Biol Cell. 1999, 10 (6): 1973-1984.PubMed CentralView ArticlePubMedGoogle Scholar
- Pomies P, Macalma T, Beckerle MC: Purification and characterization of an alpha-actinin-binding PDZ-LIM protein that is Up-regulated during muscle differentiation. J Biol Chem. 1999, 274 (41): 29242-29250. 10.1074/jbc.274.41.29242.View ArticlePubMedGoogle Scholar
- Zhou Q, Ruiz-Lozano P, Martone ME, Chen J: Cypher, a striated muscle-restricted PDZ and LIM domain-containing protein, binds to alpha-actinin-2 and protein kinase C. J Biol Chem. 1999, 274 (28): 19807-19813. 10.1074/jbc.274.28.19807.View ArticlePubMedGoogle Scholar
- Nakagawa N, Hoshijima M, Oyasu M, Saito N, Tanizawa K, Kuroda S: ENH, containing PDZ and LIM domains, heart/skeletal muscle-specific protein, associates with cytoskeletal proteins through the PDZ domain. Biochem Biophys Res Commun. 2000, 272 (2): 505-512. 10.1006/bbrc.2000.2787.View ArticlePubMedGoogle Scholar
- Passier R, Richardson JA, Olson EN: Oracle, a novel PDZ-LIM domain protein expressed in heart and skeletal muscle. Mech Dev. 2000, 92 (2): 277-284. 10.1016/S0925-4773(99)00330-5.View ArticlePubMedGoogle Scholar
- Niederlander N, Fayein NA, Auffray C, Pomies P: Characterization of a new human isoform of the enigma homolog family specifically expressed in skeletal muscle. Biochem Biophys Res Commun. 2004, 325 (4): 1304-1311. 10.1016/j.bbrc.2004.10.178.View ArticlePubMedGoogle Scholar
- Wang H, Harrison-Shostak DC, Lemasters JJ, Herman B: Cloning of a rat cDNA encoding a novel LIM domain protein with high homology to rat RIL. Gene. 1995, 165 (2): 267-271. 10.1016/0378-1119(95)00542-E.View ArticlePubMedGoogle Scholar
- Kotaka M, Ngai SM, Garcia-Barcelo M, Tsui SK, Fung KP, Lee CY, Waye MM: Characterization of the human 36-kDa carboxyl terminal LIM domain protein (hCLIM1). J Cell Biochem. 1999, 72 (2): 279-285. 10.1002/(SICI)1097-4644(19990201)72:2<279::AID-JCB12>3.0.CO;2-7.View ArticlePubMedGoogle Scholar
- Kotaka M, Kostin S, Ngai S, Chan K, Lau Y, Lee SM, Li H, Ng EK, Schaper J, Tsui SK: Interaction of hCLIM1, an enigma family protein, with alpha-actinin 2. J Cell Biochem. 2000, 78 (4): 558-565. 10.1002/1097-4644(20000915)78:4<558::AID-JCB5>3.0.CO;2-I.View ArticlePubMedGoogle Scholar
- Vallenius T, Mäkelä TP: Clik1: a novel kinase targeted to actin stress fibers by the CLP-36 PDZ-LIM protein. J Cell Sci. 2002, 115 (Pt 10): 2067-2073.PubMedGoogle Scholar
- Vallenius T, Scharm B, Vesikansa A, Luukko K, Schafer R, Mäkelä TP: The PDZ-LIM protein RIL modulates actin stress fiber turnover and enhances the association of alpha-actinin with F-actin. Exp Cell Res. 2004, 293 (1): 117-128. 10.1016/j.yexcr.2003.09.004.View ArticlePubMedGoogle Scholar
- Kiess M, Scharm B, Aguzzi A, Hajnal A, Klemenz R, Schwarte-Waldhoff I, Schafer R: Expression of ril, a novel LIM domain gene, is down-regulated in Hras-transformed cells and restored in phenotypic revertants. Oncogene. 1995, 10 (1): 61-68.PubMedGoogle Scholar
- Bashirova AA, Markelov ML, Shlykova TV, Levshenkova EV, Alibaeva RA, Frolova EI: The human RIL gene: mapping to human chromosome 5q31.1, genomic organization and alternative transcripts. Gene. 1998, 210 (2): 239-245. 10.1016/S0378-1119(98)00080-8.View ArticlePubMedGoogle Scholar
- Torrado M, Senatorov VV, Trivedi R, Fariss RN, Tomarev SI: Pdlim2, a novel PDZ-LIM domain protein, interacts with alpha-actinins and filamin A. Invest Ophthalmol Vis Sci. 2004, 45 (11): 3955-3963. 10.1167/iovs.04-0721.View ArticlePubMedGoogle Scholar
- Loughran G, Healy NC, Kiely PA, Huigsloot M, Kedersha NL, O'Connor R: Mystique is a new insulin-like growth factor-I-regulated PDZ-LIM domain protein that promotes cell attachment and migration and suppresses Anchorage-independent growth. Mol Biol Cell. 2005, 16 (4): 1811-1822. 10.1091/mbc.E04-12-1052.PubMed CentralView ArticlePubMedGoogle Scholar
- Pashmforoush M, Pomies P, Peterson KL, Kubalak S, Ross J, Hefti A, Aebi U, Beckerle MC, Chien KR: Adult mice deficient in actinin-associated LIM-domain protein reveal a developmental pathway for right ventricular cardiomyopathy. Nat Med. 2001, 7 (5): 591-597. 10.1038/87920.View ArticlePubMedGoogle Scholar
- Zhou Q, Chu PH, Huang C, Cheng CF, Martone ME, Knoll G, Shelton GD, Evans S, Chen J: Ablation of Cypher, a PDZ-LIM domain Z-line protein, causes a severe form of congenital myopathy. J Cell Biol. 2001, 155 (4): 605-612. 10.1083/jcb.200107092.PubMed CentralView ArticlePubMedGoogle Scholar
- Jani K, Schöck F: Zasp is required for the assembly of functional integrin adhesion sites. J Cell Biol. 2007, 179 (7): 1583-1597. 10.1083/jcb.200707045.PubMed CentralView ArticlePubMedGoogle Scholar
- Schulz TW, Nakagawa T, Licznerski P, Pawlak V, Kolleker A, Rozov A, Kim J, Dittgen T, Kohr G, Sheng M: Actin/alpha-actinin-dependent transport of AMPA receptors in dendritic spines: role of the PDZ-LIM protein RIL. J Neurosci. 2004, 24 (39): 8584-8594. 10.1523/JNEUROSCI.2100-04.2004.View ArticlePubMedGoogle Scholar
- Au Y, Atkinson RA, Guerrini R, Kelly G, Joseph C, Martin SR, Muskett FW, Pallavicini A, Faulkner G, Pastore A: Solution structure of ZASP PDZ domain; implications for sarcomere ultrastructure and enigma family redundancy. Structure (Camb). 2004, 12 (4): 611-622. 10.1016/j.str.2004.02.019.View ArticleGoogle Scholar
- Klaavuniemi T, Kelloniemi A, Ylänne J: The ZASP-like motif in actinin-associated LIM protein is required for interaction with the alpha-actinin rod and for targeting to the muscle Z-line. J Biol Chem. 2004, 279 (25): 26402-26410. 10.1074/jbc.M401871200.View ArticlePubMedGoogle Scholar
- Bauer K, Kratzer M, Otte M, de Quintana KL, Hagmann J, Arnold GJ, Eckerskorn C, Lottspeich F, Siess W: Human CLP36, a PDZ-domain and LIM-domain protein, binds to alpha-actinin-1 and associates with actin filaments and stress fibers in activated platelets and endothelial cells. Blood. 2000, 96 (13): 4236-4245.PubMedGoogle Scholar
- Klaavuniemi T, Ylänne J: Zasp/Cypher internal ZM-motif containing fragments are sufficient to co-localize with alpha-actinin – analysis of patient mutations. Exp Cell Res. 2006, 312 (8): 1299-1311. 10.1016/j.yexcr.2005.12.036.View ArticlePubMedGoogle Scholar
- Vatta M, Mohapatra B, Jimenez S, Sanchez X, Faulkner G, Perles Z, Sinagra G, Lin JH, Vu TM, Zhou Q: Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J Am Coll Cardiol. 2003, 42 (11): 2014-2027. 10.1016/j.jacc.2003.10.021.View ArticlePubMedGoogle Scholar
- Selcen D, Engel AG: Mutations in ZASP define a novel form of muscular dystrophy in humans. Ann Neurol. 2005, 57 (2): 269-276. 10.1002/ana.20376.View ArticlePubMedGoogle Scholar
- Te Velthuis AJ, Isogai T, Gerrits L, Bagowski CP: Insights into the molecular evolution of the PDZ/LIM family and identification of a novel conserved protein motif. PLoS ONE. 2007, 2 (2): e189-10.1371/journal.pone.0000189.PubMed CentralView ArticlePubMedGoogle Scholar
- Prilusky J, Felder CE, Zeev-Ben-Mordehai T, Rydberg EH, Man O, Beckmann JS, Silman I, Sussman JL: FoldIndex(C): a simple tool to predict whether a given protein sequence is intrinsically unfolded. Bioinformatics. 2005, 21 (16): 3435-3438. 10.1093/bioinformatics/bti537.View ArticlePubMedGoogle Scholar
- Schultz J, Milpetz F, Bork P, Ponting CP: SMART, a simplemodular architecture research tool: identification of signaling domains. Proc Natl Acad Sci USA. 1998, 95 (11): 5857-5864. 10.1073/pnas.95.11.5857.PubMed CentralView ArticlePubMedGoogle Scholar
- Linding R, Jensen LJ, Diella F, Bork P, Gibson TJ, Russell RB: Protein disorder prediction: implications for structural proteomics. Structure (Camb). 2003, 11 (11): 1453-1459. 10.1016/j.str.2003.10.002.View ArticleGoogle Scholar
- Bondos SE, Bicknell A: Detection and prevention of protein aggregation before, during, and after purification. Anal Biochem. 2003, 316 (2): 223-231. 10.1016/S0003-2697(03)00059-9.View ArticlePubMedGoogle Scholar
- Golovanov AP, Hautbergue GM, Wilson SA, Lian LY: A simple method for improving protein solubility and long-term stability. J Am Chem Soc. 2004, 126 (29): 8933-8939. 10.1021/ja049297h.View ArticlePubMedGoogle Scholar
- Alho N, Klaavuniemi T, Ylänne J, Permi P, Mattila S: Backbone NMR assignment of the internal interaction site of ALP. Biomolecular NMR Assignments. 2007, 1 (1): 85-10.1007/s12104-007-9024-1.View ArticlePubMedGoogle Scholar
- Spera S, Bax A: Empirical correlation between protein backbone conformation and Calpha and Cbeta 13-C nuclear magnetic resonance chemical shifts. J Am Chem Soc. 1991, 113: 5490-5492. 10.1021/ja00014a071.View ArticleGoogle Scholar
- Small JV: Structure-function relationships in smooth muscle: the missing links. BioEssays. 1995, 17 (9): 785-792. 10.1002/bies.950170908.View ArticlePubMedGoogle Scholar
- Vlahos CJ, McDowell SA, Clerk A: Kinases as therapeutic targets for heart failure. Nat Rev Drug Discov. 2003, 2 (2): 99-113. 10.1038/nrd1009.View ArticlePubMedGoogle Scholar
- Wilkins BJ, Molkentin JD: Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem Biophys Res Commun. 2004, 322 (4): 1178-1191. 10.1016/j.bbrc.2004.07.121.View ArticlePubMedGoogle Scholar
- Vega RB, Bassel-Duby R, Olson EN: Control of cardiac growth and function by calcineurin signaling. J Biol Chem. 2003, 278 (39): 36981-36984. 10.1074/jbc.R300023200.View ArticlePubMedGoogle Scholar
- Kuroda S, Tokunaga C, Kiyohara Y, Higuchi O, Konishi H, Mizuno K, Gill GN, Kikkawa U: Protein-protein interaction of zinc finger LIM domains with protein kinase C. J Biol Chem. 1996, 271 (49): 31029-31032. 10.1074/jbc.271.49.31029.View ArticlePubMedGoogle Scholar
- Frey N, Olson EN: Calsarcin-3, a novel skeletal muscle-specific member of the calsarcin family, interacts with multiple Z-disc proteins. J Biol Chem. 2002, 277 (16): 13998-14004. 10.1074/jbc.M200712200.View ArticlePubMedGoogle Scholar
- Djinovic-Carugo K, Young P, Gautel M, Saraste M: Structure of the alpha-actinin rod: molecular basis for cross-linking of actin filaments. Cell. 1999, 98 (4): 537-546. 10.1016/S0092-8674(00)81981-9.View ArticlePubMedGoogle Scholar
- Ylänne J, Scheffzek K, Young P, Saraste M: Crystal Structure of the alpha-Actinin Rod Reveals an Extensive Torsional Twist. Structure. 2001, 9 (7): 597-604. 10.1016/S0969-2126(01)00619-0.View ArticlePubMedGoogle Scholar
- Hotulainen P, Lappalainen P: Stress fibers are generated by two distinct actin assembly mechanisms in motile cells. J Cell Biol. 2006, 173 (3): 383-394. 10.1083/jcb.200511093.PubMed CentralView ArticlePubMedGoogle Scholar
- Sambrook J, Russell DW: Molecular Cloning, a laboratory mamual. 2001, New York: Cold Spring Harbor Laboratory Press, 3Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.